Skip to main content
Fig. 4 | BMC Musculoskeletal Disorders

Fig. 4

From: Clinical trial and in-vitro study comparing the efficacy of treating bony lesions with allografts versus synthetic or highly-processed xenogeneic bone grafts

Fig. 4

Cell viability of hOB cultured on either ACB or BioOss® was measured using the AlamarBlue® assay. Cells were vital during the 3-week culture period independent of the biomaterial used. No significant differences appeared between the two intervention groups and various points concerning cell viability and proliferation

Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us